SARS-CoV-2 might direct damage β-cells via cell surface ACE2 protein and lead to cell injury and apoptosis causing relative insulin deficiency and acute hyperglycemic state, thereby increasing the risk for developing severe COVID-19 or requiring ICU admission (Hussain et al., 2020). The gene discussed is ACE2; the disease is COVID-19.